Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 340 followers
Latest posts
Last updated about 1 hour ago
Roche nabs expanded FDA approval for diagnostic tied to Jazz’s cancer drug
about 1 hour ago
Roche has been given an extended clearance by the FDA for its...
Flagship’s ProFound partners with Gates Foundation in $35M preeclampsia target discovery pact
about 3 hours ago
Flagship Pioneering’s ProFound Therapeutics is keeping its string of high-profile partnerships going...
Medigen links up with Charles River in push to take enterovirus vaccine global
about 17 hours ago
Charles River Laboratories and Taiwan-based Medigen Vaccine Biologics are teaming up to...
McKesson strikes $2.25B deal to snap up Precision Medicine Group
about 20 hours ago
The healthcare conglomerate, which ranks eighth on the Fortune 500 list, is...
FDA greenlights Abbott’s wearable sensor for capturing diabetic ketoacidosis
about 21 hours ago
The FDA has approved Abbott’s first-of-its-kind bio-wearable sensor that can warn diabetics...
Akeso CEO looks beyond lung cancer with biliary tract win, counters ivonescimab debate
about 21 hours ago
Fresh off a phase 3 win in biliary tract cancer, Akeso CEO...
FDA greenlights Revolution Medicines' pancreatic cancer gamechanger
about 21 hours ago
Following dynamite data that earned a standing ovation at the American Society...
Hansoh heralds China’s move from ‘follower’ to ‘frontrunner’ in biopharma race
about 23 hours ago
Hansoh Pharmaceutical has given a bullish assessment of China’s innovative pharma sector...
JATT mastermind launches latest biotech-focused SPAC via $60M IPO
about 23 hours ago
Just two months after Someit Sidhu, M.D., succeeded in pairing off his...
Boston Scientific hit by cyberattack causing ‘disruptions’ to parts of its business
1 day ago
This year has seen a growing number of medtechs hit by cyberattacks...
Spyre’s rheumatoid arthritis plan toppled by subpar TL1A data
1 day ago
Phase 2 data on Spyre Therapeutics’ anti-TL1A antibody SPY072 in rheumatoid arthritis...
SK Biopharma pens $795M deal to usher Biohaven’s epilepsy therapy towards hoped-for 2029 launch
1 day ago
SK Biopharmaceuticals has strengthened its epilepsy offering by paying $350 million upfront...